Masuk tirto.id
Jadikan tirto.id sumber pilihan pencarian Google
We are advised by IASO Bio that journalists and other readers should disregard the news release, IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics, issued 13-Aug-2026 over PR Newswire, as the release contained erroneous information.
Sumber: www.prnasia.com
Disclaimer: This press release was supplied by a third party. Tirto is not involved in its preparation and bears no responsibility for its content.
Reporter: PR Newswire
Penulis: PR Newswire
Editor: PR Newswire
Penulis: PR Newswire
Editor: PR Newswire
